Colon Cancer Stage III Clinical Trial
Official title:
A Prospectively Randomized Phase III Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Patients With Operated Colon Carcinoma Dukes C (Stage III; T1-4, N1-30, M0).
This clinical investigation examined the effectivity 5-fluorouracil, of adding levamisol or interferon to 5-fluorouracil, and of a 5-fluorouracil/levamisol/interferon triple combination, in terms of recurrence-free and overall survival in curatively operable colon carcinoma Stage III.
n/a
Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04907643 -
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
|
N/A | |
Completed |
NCT04342676 -
Lymph Node Ratio and Kras Mutation in R Colon Cancer
|
Phase 3 | |
Enrolling by invitation |
NCT05179889 -
Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer
|
Phase 2/Phase 3 | |
Withdrawn |
NCT05433402 -
Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer
|
Phase 1/Phase 2 | |
Recruiting |
NCT06108310 -
ArTificial inTelligence-based RAdiogenomics in Colon Tumors
|
||
Withdrawn |
NCT05310565 -
The Effects of Chiropractic in Adults With Colon Cancer
|
N/A | |
Not yet recruiting |
NCT04488159 -
Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer
|
Phase 3 | |
Recruiting |
NCT05194878 -
Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers
|
Phase 3 |